Braemar Charitable Trust, owner of Braemar Hospital Limited, has announced the appointment of Graeme Milne (ONZM) as the incoming Chair of the Hospital’s Board of Directors. Mr Milne took up the role on 1st October.
Mr Milne qualified as a biochemical engineer and worked initially in the pharmaceutical and brewing industries before joining the New Zealand Dairy Board where he worked both nationally and abroad in various executive roles. He was CEO of Bay Milk Products and the New Zealand Dairy Group before the formation of Fonterra and interim CEO of Richmond and Bonlac in Australia.
Mr Milne has been a professional director for the last twenty years and is currently Chair of Synlait Milk, PF Olsen and Nyriad and is a director of the Alliance Group. He was the Chair of the Waikato DHB for just under five years during the major rebuild of the Waikato Hospital and was, until recently, on the Board of New Zealand Pharmaceuticals.
Chair of Braemar Charitable Trust, Mr Chris O'Meeghan, said that Trustees were delighted to attract someone of Mr Milne’s experience and expertise to the role.
“Graeme’s skills will complement the institutional knowledge and health sector and clinical expertise of the incumbent Medical Associate directors and the broader commercial experience of recently appointed independent directors, Renae Smart and Bella Takiari-Brame.”
Mr. Milne said “I am delighted to be appointed and am looking forward to contributing to Braemar Hospital as it continues as a major provider of surgical and medical services in the Waikato, and also delivering on the objectives of the Trust.”
Mr Milne replaces previous Chair Graham Naylor who retired from the role in late September. Mr Chris O’Meeghan acknowledged Mr Naylor’s tenure as Chair and thanked him for his significant contribution to Braemar Hospital, which will be formally recognised by the Trust Board later this mon